Boehringer Ingelheim International GmbH introduced Fencovis, a new vaccine for preventing calf diarrhea caused by E. coli F5 and bovine rotavirus. The vaccine provides passive immunity through the colostrum of cows.
Zoetis Inc. has acquired Basepaws, a privately held pet care genetics company that delivers pet owners with genetic tests, analytics, and early health risk assessments of pets.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 1225
Published Date: Feb 06, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Upsurge in zoonotic diseases, escalating number of livestock, growing prevalence of diabetes in pets are some major factors driving the growth of the market.
The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 202-2033.
Stringent government policies on approval of animal drugs, price hike in animal health products, and escalating cost of animal testing are estimated to hamper the market growth.
The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, animal type, end-user, distribution channel, and by region.
The pharmaceuticals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.